在与艾滋病毒相关的神经认知障碍中的谷氨
Thomas Erdos1, Mika Masuda1, Vishwanath Venketaraman1
1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Current issues in molecular biology
|June 26, 2024
概括
谷氨补充剂可能有助于一些患有人类免疫缺陷病毒 (HIV) 相关的神经认知障碍 (HAND) 的患者. 然而,益处因特定的神经认知状况而异,因为氧化应激在HAND病变发生过程中起着关键作用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 人类免疫缺陷病毒 (HIV) 感染经常导致神经系统并发症.
- 虽然抗逆转录病毒疗法可以改善艾滋病毒的控制,但它们往往无法完全解决神经症状.
- 氧化应激是艾滋病毒相关神经认知障碍 (HAND) 病变的一个重要因素.
研究的目的:
- 对各种与艾滋病毒相关的神经认知疾病的谷氨补充剂的现有试验进行审查.
- 在试验不完整的情况下,根据潜在的病理机制预测谷氨的疗效.
- 为了确定谷氨是否为所有形式的手工提供了普遍的好处.
主要方法:
- 对临床试验的文献综述,研究了HAND.中的谷氨补充剂.
- 分析将氧化应激与艾滋病毒中特定的神经认知状况联系在一起的病理机制.
- 基于科学文献的潜在治疗反应的推断.
主要成果:
- 谷氨补充剂在审查的与艾滋病毒相关的神经认知疾病中显示了疾病特异性结果.
- 预测的反应表明,在不同的HAND亚型中,谷氨的疗效不同.
- 谷氨的抗氧化作用并非对所有人都是普遍有益的.
结论:
- 在HAND中补充谷氨的有效性取决于特定的神经认知疾病.
- 了解每个HAND亚型的独特病理机制对于预测治疗结果至关重要.
- 需要进一步的研究来阐明谷氨在管理各种HAND表现中的确切作用.
相关概念视频
Role of Neurotransmitters in Memory
519
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
519
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178


